1 Product identity
Ingredient risk
1 ingredient to use with caution
Vitamin D3 125 mcg
BrandAvPAK→Vitamin Softgel Capsule 6 ingredients 1 caution DSLD #272934Net contents: 50 Softgel(s)
Target: Adults and Children 4 years and above
DSLD entry: 2022-08-23
2 Ingredients (6)
IngredientGroupSafety
Soybean OilSoybean Oil—
GelatinGelatin—
GlycerinGlycerol—
purified WaterWater—
Corn OilCorn Oil—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Vitamin D — Granulomatous diseases (sarcoidosis, TB) — unregulated extra-renal CYP27B1 can cause life-threatening hypercalcemia even at standard doses [2][21]
3 Safety cross-reference
Vitamin D — Use with Caution
⚠ Hypercalcemia at >10,000 IU/day
⚠ Vascular calcification risk
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID272934
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2022-08-23
6 More from AvPAK
View AvPAK Safety Scorecard → 14 products
A 3000 mcgCalcium 600+D3Calcium Citrate Maximum +D3Chewable C 500 mgFolic Acid 800 mcgFolic Acid 800 mcg7 Cite this page
Vancouver
Pkhakadze G. Vitamin D3 125 mcg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 24]. Available from: https://supplement.ge/products/vitamin-d3-125-mcg-272934/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG